Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2018
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen
Charlotte Charpentier, Isabelle Malet, Elisabeth Andre-Garnier, et al.
International Journal of Antimicrobial Agents
|
April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure
Anne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma
Cathia Soulie, Diane Descamps, Maxime Grudé, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011
Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
The Journal of Antimicrobial Chemotherapy
|
February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Anne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
October 24, 2019
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
Benoit Visseaux, Lambert Assoumou, Nadia Mahjoub, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2017
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma
Cathia Soulie, Maxime Grudé, Diane Descamps, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 16, 2017
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen
Stéphanie Raymond, Florence Nicot, Coralie Pallier, et al.
The Journal of Antimicrobial Chemotherapy
|
June 8, 2021
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey
Anne-Genevieve Marcelin, Charlotte Charpentier, Pantxika Bellecave, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2019
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France
Lambert Assoumou, Laurence Bocket, Coralie Pallier, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2018
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen
Charlotte Charpentier, Isabelle Malet, Elisabeth Andre-Garnier, et al.
International Journal of Antimicrobial Agents
|
April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure
Anne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma
Cathia Soulie, Diane Descamps, Maxime Grudé, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011
Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
The Journal of Antimicrobial Chemotherapy
|
February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Anne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
October 24, 2019
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
Benoit Visseaux, Lambert Assoumou, Nadia Mahjoub, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2017
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma
Cathia Soulie, Maxime Grudé, Diane Descamps, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 16, 2017
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen
Stéphanie Raymond, Florence Nicot, Coralie Pallier, et al.
The Journal of Antimicrobial Chemotherapy
|
June 8, 2021
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey
Anne-Genevieve Marcelin, Charlotte Charpentier, Pantxika Bellecave, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2019
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France
Lambert Assoumou, Laurence Bocket, Coralie Pallier, et al.
Page
of 5